PPAR-activatoren

PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly...

Full description

Saved in:
Bibliographic Details
Main Authors WILLIAM ANDREW HADA, ZHENGYU LIU, ROBERT WAYNE DUGGER, CHERYL MYERS HAYWARD, SCOTT WILLIAM BAGLEY, THOMAS ANDREW BRANDT
Format Patent
LanguageDutch
Published 16.09.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:PPAR alpha activators, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases, in mammals, including humans.
Bibliography:Application Number: NL20031024881